Immune reactivity to type VII collagen: implications for gene therapy of recessive dystrophic epidermolysis bullosa.
#
Previous PostA frequent functional SNP in the MMP-1 promoter is associated with a higher disease severity in Recessive Dystrophic Epidermolysis Bullosa.
Next PostBlack Patients of African descent and HLA-DRB*1503 frequency Overrepresented in a French Cohort of Epidermolysis Bullosa Acquisita.
